Implant device for incontinence reaches milestone
A popular treatment for severe male urinary incontinence reached a major milestone last month: 100,000 implants, according to its manufacturer, American Medical Systems.
A popular treatment for severe male urinary incontinence reached a major milestone last month: 100,000 implants, according to its manufacturer, American Medical Systems.
“The AMS 800 is the leading surgical treatment option for moderate to severe urinary incontinence in males because of its safety, efficacy, and high level of patient satisfaction,” said Martin J. Emerson, president and CEO of AMS. “Reaching the landmark of 100,000 implants demonstrates that physicians across the globe recognize its benefits and superior clinical outcomes.
“Our physician partners around the world have made the AMS 800 the gold standard for treatment for men with moderate to severe urinary incontinence. The physicians implanting the AMS 800 are industry leaders, and they demand a ‘best-in-class’ solution.”
The product uses a fully implanted technology to restore normal sphincter function by opening and closing the urethra under patient control, thereby offering patients the opportunity to achieve continence.
Study finds disparities in management of mCSPC
April 17th 2024“These findings suggest that guideline recommended treatment intensification remains low for patients with mCSPC in both Medicare and the Veterans Health Administration, but especially for Black patients,” says Daniel J. George, MD.
